The race is on to make the first oral weight loss medicines, but smaller US pharmacies may have already got there – if they ...

Eli Lilly (LLY) will soon be releasing trial data on its small-molecule GLP-1 weight-loss pill, Orforglipron. The drug could ...

Novo Nordisk leads a GLP-1 agonist market that could surpass $150 billion by 2035. Ironically, the market is passing on the ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the ...

Recent figures suggest more than half a million people in the UK are taking Mounjaro or Wegovy (the version of Ozempic approved for weight loss, rather than diabetes control, although private ...

It may soon be replaced by a new model designed as a more affordable version of the Tuft & Needle Original. If that happens, this article will link to the updated model. The Nod mattress is what I ...

Gill Riley, from Warrington, Cheshire, started using the weight-loss injections, which work by mimicking hormones that control appetite and digestion, back in September.

Ozempic and Wegovy are both semaglutides or GLP-1 drugs ... Messer describes the needle as “small, the size of two human hairs.” Oftentimes, her office will teach the patient how to inject ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Fact checked by Nick Blackmer Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price for people who are uninsured or insured on commercial plans that don't ...